Medical News |
- Maternal influenza link to mood in children
- Maternal influenza link to mood in children
- Psychotic experiences show continuum from childhood
- Psychotic experiences show continuum from childhood
- Thalidomide fails to boost mesothelioma outcomes
- S-1 combination regimen effective for NSCLC
- Gene fusion reduces NSCLC patient survival
- Hsp90 inhibitor shows NSCLC promise
- TKI resistance markers found for NSCLC patients
- <i>KRAS</i> oncogene substitutions may be predictive in lung adenocarcinoma
- Burden of symptoms could guide NSCLC pemetrexed use
- Thalidomide fails to boost mesothelioma outcomes
- S-1 combination regimen effective for NSCLC
- Gene fusion reduces NSCLC patient survival
- Hsp90 inhibitor shows NSCLC promise
- TKI resistance markers found for NSCLC patients
- <i>KRAS</i> oncogene substitutions may be predictive in lung adenocarcinoma
- Burden of symptoms could guide NSCLC pemetrexed use
- Thalidomide fails to boost mesothelioma outcomes
- S-1 combination regimen effective for NSCLC
- Gene fusion reduces NSCLC patient survival
- Hsp90 inhibitor shows NSCLC promise
- TKI resistance markers found for NSCLC patients
- <i>KRAS</i> oncogene substitutions may be predictive in lung adenocarcinoma
- Burden of symptoms could guide NSCLC pemetrexed use
- Gene variants linked to childhood acetaminophen–asthma risk
| Maternal influenza link to mood in children Posted: 08 May 2013 05:00 PM PDT The children of women who have influenza while pregnant have an increased risk for developing bipolar disorder in later life, a prospective study suggests. |
| Maternal influenza link to mood in children Posted: 08 May 2013 05:00 PM PDT The children of women who have influenza while pregnant have an increased risk for developing bipolar disorder in later life, a prospective study suggests. |
| Psychotic experiences show continuum from childhood Posted: 08 May 2013 05:00 PM PDT Researchers have found evidence of a continuum of psychotic experiences from as early as 12 years old, but the positive predictive value of such early experiences appears too low to make targeted interventions a feasible option. |
| Psychotic experiences show continuum from childhood Posted: 08 May 2013 05:00 PM PDT Researchers have found evidence of a continuum of psychotic experiences from as early as 12 years old, but the positive predictive value of such early experiences appears too low to make targeted interventions a feasible option. |
| Thalidomide fails to boost mesothelioma outcomes Posted: 07 May 2013 05:00 PM PDT Adding maintenance thalidomide to standard first-line chemotherapy does not improve outcomes among patients with malignant pleural or peritoneal mesothelioma, study findings indicate. |
| S-1 combination regimen effective for NSCLC Posted: 07 May 2013 05:00 PM PDT Researchers suggest that combined therapy with the fluoropyrimidine S-1, carboplatin, and bevacizumab followed by maintenance therapy with S-1 and bevacizumab should be first-line treatment for patients with advanced non-squamous non-small-cell lung cancer. |
| Gene fusion reduces NSCLC patient survival Posted: 07 May 2013 05:00 PM PDT ROS1 fusions predict a poor outcome in Chinese patients with non-small-cell lung cancer, study findings suggest. |
| Hsp90 inhibitor shows NSCLC promise Posted: 07 May 2013 05:00 PM PDT Treatment with a heatshock protein 90 inhibitor may induce loss of EML4-AKL expression in non-small cell lung cancer cells, preliminary results suggest. |
| TKI resistance markers found for NSCLC patients Posted: 07 May 2013 05:00 PM PDT Korean scientists have identified several genetic markers that may explain lack of response to tyrosine kinase inhibitor therapy in patients with epidermal growth factor receptor-activating, non-small-cell lung cancer. |
| <i>KRAS</i> oncogene substitutions may be predictive in lung adenocarcinoma Posted: 07 May 2013 05:00 PM PDT Researchers have found that certain KRAS oncogene substitutions may have predictive value in lung adenocarcinoma. |
| Burden of symptoms could guide NSCLC pemetrexed use Posted: 07 May 2013 05:00 PM PDT Symptom burden and performance status may help identify the patients with non-squamous non-small-cell lung cancer who are likely to respond to maintenance pemetrexed therapy, phase III trial findings suggest. |
| Thalidomide fails to boost mesothelioma outcomes Posted: 07 May 2013 05:00 PM PDT Adding maintenance thalidomide to standard first-line chemotherapy does not improve outcomes among patients with malignant pleural or peritoneal mesothelioma, study findings indicate. |
| S-1 combination regimen effective for NSCLC Posted: 07 May 2013 05:00 PM PDT Researchers suggest that combined therapy with the fluoropyrimidine S-1, carboplatin, and bevacizumab followed by maintenance therapy with S-1 and bevacizumab should be first-line treatment for patients with advanced non-squamous non-small-cell lung cancer. |
| Gene fusion reduces NSCLC patient survival Posted: 07 May 2013 05:00 PM PDT ROS1 fusions predict a poor outcome in Chinese patients with non-small-cell lung cancer, study findings suggest. |
| Hsp90 inhibitor shows NSCLC promise Posted: 07 May 2013 05:00 PM PDT Treatment with a heatshock protein 90 inhibitor may induce loss of EML4-AKL expression in non-small cell lung cancer cells, preliminary results suggest. |
| TKI resistance markers found for NSCLC patients Posted: 07 May 2013 05:00 PM PDT Korean scientists have identified several genetic markers that may explain lack of response to tyrosine kinase inhibitor therapy in patients with epidermal growth factor receptor-activating, non-small-cell lung cancer. |
| <i>KRAS</i> oncogene substitutions may be predictive in lung adenocarcinoma Posted: 07 May 2013 05:00 PM PDT Researchers have found that certain KRAS oncogene substitutions may have predictive value in lung adenocarcinoma. |
| Burden of symptoms could guide NSCLC pemetrexed use Posted: 07 May 2013 05:00 PM PDT Symptom burden and performance status may help identify the patients with non-squamous non-small-cell lung cancer who are likely to respond to maintenance pemetrexed therapy, phase III trial findings suggest. |
| Thalidomide fails to boost mesothelioma outcomes Posted: 07 May 2013 05:00 PM PDT Adding maintenance thalidomide to standard first-line chemotherapy does not improve outcomes among patients with malignant pleural or peritoneal mesothelioma, study findings indicate. |
| S-1 combination regimen effective for NSCLC Posted: 07 May 2013 05:00 PM PDT Researchers suggest that combined therapy with the fluoropyrimidine S-1, carboplatin, and bevacizumab followed by maintenance therapy with S-1 and bevacizumab should be first-line treatment for patients with advanced non-squamous non-small-cell lung cancer. |
| Gene fusion reduces NSCLC patient survival Posted: 07 May 2013 05:00 PM PDT ROS1 fusions predict a poor outcome in Chinese patients with non-small-cell lung cancer, study findings suggest. |
| Hsp90 inhibitor shows NSCLC promise Posted: 07 May 2013 05:00 PM PDT Treatment with a heatshock protein 90 inhibitor may induce loss of EML4-AKL expression in non-small cell lung cancer cells, preliminary results suggest. |
| TKI resistance markers found for NSCLC patients Posted: 07 May 2013 05:00 PM PDT Korean scientists have identified several genetic markers that may explain lack of response to tyrosine kinase inhibitor therapy in patients with epidermal growth factor receptor-activating, non-small-cell lung cancer. |
| <i>KRAS</i> oncogene substitutions may be predictive in lung adenocarcinoma Posted: 07 May 2013 05:00 PM PDT Researchers have found that certain KRAS oncogene substitutions may have predictive value in lung adenocarcinoma. |
| Burden of symptoms could guide NSCLC pemetrexed use Posted: 07 May 2013 05:00 PM PDT Symptom burden and performance status may help identify the patients with non-squamous non-small-cell lung cancer who are likely to respond to maintenance pemetrexed therapy, phase III trial findings suggest. |
| Gene variants linked to childhood acetaminophen–asthma risk Posted: 07 May 2013 05:00 PM PDT Researchers have found several gene polymorphisms that are associated with an increased risk for childhood asthma after acetaminophen consumption in early life. |
| You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google Inc., 20 West Kinzie, Chicago IL USA 60610 | |
No comments:
Post a Comment